Data gathered: October 17
Alternative Data for Aslan Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 90 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Employee Rating | 88 | Sign up | Sign up | Sign up |
| Google Trends | 7 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,425 | Sign up | Sign up | Sign up |
| Twitter Followers | 274 | Sign up | Sign up | Sign up |
| Twitter Mentions | 5 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 45 | Sign up | Sign up | Sign up |
About Aslan Pharmaceuticals
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients.
| Price | $0.60 |
| Target Price | Sign up |
| Volume | 806,350 |
| Market Cap | $1.7M |
| Year Range | $0.6 - $13.04 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Aslan Pharmaceuticals commences steps to place itself in voluntary liquidationJuly 17 - Thefly.com |
Aslan Pharmaceuticals Begins Voluntary LiquidationJuly 16 - TipRanks |
|
|
Aslan Pharmaceuticals receives Nasdaq delisting determination, will not appealJuly 15 - Thefly.com |
 |
ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Short Interest Down 85.8% in JuneJuly 13 - ETF Daily News |
|
ASLAN Pharmaceuticals Stock Set to Reverse Split on Wednesday, July 3rd (NASDAQ:ASLN)June 24 - ETF Daily News |
Aslan Pharmaceuticals plans to implement ADS ratio changeJune 13 - Thefly.com |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 0 | 0 | 0 | -9.9M | -9.3M | -0.780 |
| Q4 '23 | 0 | 0 | 0 | -14M | 0 | -0.780 |
| Q3 '23 | 0 | 0 | 0 | -9.7M | -8.5M | -0.560 |
| Q2 '23 | 12M | 0 | 12M | -9.7M | -8.5M | -0.110 |
| Q1 '23 | 0 | 0 | 0 | -19M | -18M | -1.290 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Aslan Pharmaceuticals (ASLN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Aslan Pharmaceuticals?
The Market Cap of Aslan Pharmaceuticals is $1.7M.
What is the current stock price of Aslan Pharmaceuticals?
Currently, the price of one share of Aslan Pharmaceuticals stock is $0.60.
How can I analyze the ASLN stock price chart for investment decisions?
The ASLN stock price chart above provides a comprehensive visual representation of Aslan Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aslan Pharmaceuticals shares. Our platform offers an up-to-date ASLN stock price chart, along with technical data analysis and alternative data insights.
Does ASLN offer dividends to its shareholders?
As of our latest update, Aslan Pharmaceuticals (ASLN) does not offer dividends to its shareholders. Investors interested in Aslan Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Aslan Pharmaceuticals?
Some of the similar stocks of Aslan Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.